Fortune Magazine on California Stem Cell Agency: Warm, Personal and Favorable
By Dr. Matthew Watson
California's $3 billion stem cell
research effort today garnered a handsome dollop of favorable
national news coverage– a lengthy piece in Fortune magazine that
spoke of looming stem cell cures and the leading role of the state
stem cell agency.
likely will be read by tens of thousands of persons, although it was not the cover story on the print product.
the magazine, Jeffrey O'Brien of Mill Valley, Ca., the piece was warm
and personal. He began with the story of his 95-year-old
grandmother and her health issues, ranging from arthritis to macular
degeneration. And he wrote,
“The citizens of California have
spoken. If my grandmother and I had the power to get the rest of the
country to follow, we would.”
finances of the stem cell business. He said,
“To be clear, the earliest stem cell
therapies are almost certainly years from distribution. But so much
progress has been made at venerable research institutions that it now
seems possible to honestly discuss the possibility of a new medical
paradigm emerging within a generation. Working primarily with rodents
in preclinical trials, MDs and Ph.D.s are making the paralyzed walk
and the impotent virile. A stem cell therapy for two types of macular
degeneration recently restored the vision of two women. Once they
were blind. Now they see!“Some experts assert that AMD could
be eradicated within a decade. Other scientists are heralding a
drug-free fix for HIV/AIDS. Various forms of cancer, Parkinson's,
diabetes, heart disease, stroke, and ALS have already been eradicated
in mice. If such work translates to humans, it will represent the
type of platform advancement that comes along in medicine only once
in a lifetime or two. The effect on the economy would be substantial.
Champions of stem cell research say it would be on the order of the
Internet or even the transistor.”
“The obstacles along the road from
lab rat to human patients are many, of course, but the biggest by far
is money. With the dramatic events in the lab, you might think that a
gold rush would be under way. That's far from true. Long time
horizons, regulatory hurdles, huge R&D costs, public sentiment,
and political headwinds have all scared financiers. Wall Street isn't
interested in financing this particular dream. Most stem cell
companies that have dared go public are trading down 90% or more from
their IPOs. Sand Hill Road is AWOL. The National Venture Capital
Association doesn't even have a category to track stem cell
investments.”
itself, the article contained remarks from its Chairman J.T.Thomas,
President Alan Trounson and former chairman Robert Klein about the origins and progress of the California Institute for Regenerative Medicine (CIRM).
“The $1.7 billion awarded so far has made one obvious mark on the state: a dozen gleaming research institutions. CIRM has proved adept at getting billionaires to donate funds to the cause.”
prominent businessmen who have contributed tens of millions of
dollars to stem cell research “about the prospects of a legitimate industry emerging.” One was “bond genius” Bill Gross, who has
contributed to UC Irvine. Gross replied.
“Goodness, you're talking to the
wrong guy. Our donation had nothing to do with business.”
said pretty much the same thing. And Andy Grove, the former chairman
of Intel, was “surprisingly full of doom and gloom.” O'Brien
wrote,
“For close to two hours, Grove argues
passionately about how the FDA is enabling predatory offshore
industries by impeding progress and the many reasons financiers want
no part of stem cells. "VCs aren't interested because it's a
shitty business," he says. Big Pharma? Forget it. CIRM? "There
are gleaming fucking buildings everywhere. That wasn't necessary."
When I press him to be constructive, he wearily offers one possible
solution. Rather than courting billionaires to put their names on
buildings, we need a system of targeted philanthropy in which the 99%
can sponsor the individual stem cell lines that matter to them.”
“It was clear during our talk that
Grove wants an economic model for stem cell research and development
to emerge, even if he's not willing to bet money on its happening.
And that puts him in good company.”
negative points about stem cell research, it is about as laudatory as
it is going to get at this point for the California stem cell agency.
The piece recognizes and even celebrates much of the work of the
agency. The article clearly details the void in financing
for commercialization of stem cell research, bolstering support for
efforts like those in California. Importantly, it also helps to push
the activities of the stem cell agency more fully into the national
discussion of stem cell research and its future. That should pay off
again and again in future news coverage and also benefit the stem
cell agency as it explores the possibility of additional funding –
either private or public – after the cash for new awards runs out
in 2017.
Source:
http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss
- 001 International Stem Cell Corporation Provides Strategic Update on its Skin Care Program [Last Updated On: April 9th, 2010] [Originally Added On: April 9th, 2010]
- 002 CSC news roundup 2010-04-11 [Last Updated On: April 12th, 2010] [Originally Added On: April 12th, 2010]
- 003 International Stem Cell Corporation Engages Leading Immunogeneticists to Advance its Industry-first, Immune-matched Stem Cells [Last Updated On: April 14th, 2010] [Originally Added On: April 14th, 2010]
- 004 MicroRNA therapy could be a powerful tool to correct the CSC dysregulation? [Last Updated On: April 17th, 2010] [Originally Added On: April 17th, 2010]
- 005 CSC news links 2010-04-18 [Last Updated On: April 19th, 2010] [Originally Added On: April 19th, 2010]
- 006 Sessions on CSC Therapeutics at AACR10 [Last Updated On: April 27th, 2010] [Originally Added On: April 27th, 2010]
- 007 More about presentations at AACR10 [Last Updated On: May 2nd, 2010] [Originally Added On: May 2nd, 2010]
- 008 International Stem Cell Corporation Signs Financing Agreement [Last Updated On: May 6th, 2010] [Originally Added On: May 6th, 2010]
- 009 CSC news links 2010-05-08 [Last Updated On: May 9th, 2010] [Originally Added On: May 9th, 2010]
- 010 International Stem Cell and Absorption Systems Confirm Results Showing Stem Cell Derived Corneal Tissue as an Alternative to Animals for Drug Testing [Last Updated On: May 12th, 2010] [Originally Added On: May 12th, 2010]
- 011 Generic drug a potential treatment for glioblastoma? [Last Updated On: May 14th, 2010] [Originally Added On: May 14th, 2010]
- 012 US Patent: Isolation and use of solid tumor stem cells [Last Updated On: May 18th, 2010] [Originally Added On: May 18th, 2010]
- 013 International Stem Cell Corporation and The Automation Partnership Enter into Strategic Alliance to Automate Cornea Tissue Production [Last Updated On: May 19th, 2010] [Originally Added On: May 19th, 2010]
- 014 An evolving concept of CSC in tumor biology [Last Updated On: May 21st, 2010] [Originally Added On: May 21st, 2010]
- 015 International Stem Cell Corporation Moves International Cornea Development Program Forward [Last Updated On: May 26th, 2010] [Originally Added On: May 26th, 2010]
- 016 Phase I clinical trial of ICT-107 [Last Updated On: June 3rd, 2010] [Originally Added On: June 3rd, 2010]
- 017 CSCs responsible for metastasis identified [Last Updated On: June 6th, 2010] [Originally Added On: June 6th, 2010]
- 018 International Stem Cell Corporation's Parthenogenetic Stem Cell Patent is Approved by the United States Patent and Trademark Office [Last Updated On: June 9th, 2010] [Originally Added On: June 9th, 2010]
- 019 International Stem Cell Corporation Announces Company Update Conference Call. ISCO Chairman Kenneth Aldrich to Discuss 'Status of the Company' [Last Updated On: June 10th, 2010] [Originally Added On: June 10th, 2010]
- 020 Decitabine may target ovarian CSCs? [Last Updated On: June 14th, 2010] [Originally Added On: June 14th, 2010]
- 021 New Article from North County Times - BIOTECH: International Stem Cell Clears Debt, Gets Patent [Last Updated On: June 17th, 2010] [Originally Added On: June 17th, 2010]
- 022 Patent application: Levels of Oct1 as a method of identifying CSCs [Last Updated On: June 18th, 2010] [Originally Added On: June 18th, 2010]
- 023 OncoMed Has 'Wnt' in its Sails [Last Updated On: June 21st, 2010] [Originally Added On: June 21st, 2010]
- 024 International Stem Cell Corporation Names Charles J. Casamento to Board of Directors [Last Updated On: June 23rd, 2010] [Originally Added On: June 23rd, 2010]
- 025 International Stem Cell Corporation (ISCO.OB) Announces New Patent Issuance Under License Agreement [Last Updated On: June 25th, 2010] [Originally Added On: June 25th, 2010]
- 026 California Health Institute Interviews Jeffrey Janus - CEO of Lifeline Cell Technology [Last Updated On: June 29th, 2010] [Originally Added On: June 29th, 2010]
- 027 International Stem Cell Corporation - Excerpt from Agora Financial's Breakthrough Technology Alert by Patrick Cox [Last Updated On: July 1st, 2010] [Originally Added On: July 1st, 2010]
- 028 Melanoma-initiating cells identified [Last Updated On: July 2nd, 2010] [Originally Added On: July 2nd, 2010]
- 029 International Stem Cell Corporation and Sankara Nethralaya Launch Collaboration to Develop Stem Cell-Based Treatment for Corneal Vision Impairment [Last Updated On: July 8th, 2010] [Originally Added On: July 8th, 2010]
- 030 Two recent OA articles [Last Updated On: July 12th, 2010] [Originally Added On: July 12th, 2010]
- 031 Innovative Researcher Vlog [Last Updated On: July 16th, 2010] [Originally Added On: July 16th, 2010]
- 032 More about salinomycin [Last Updated On: July 19th, 2010] [Originally Added On: July 19th, 2010]
- 033 International Stem Cell Corporation Plans $10 Million Financing Through European Subsidiary [Last Updated On: July 23rd, 2010] [Originally Added On: July 23rd, 2010]
- 034 Irradiating brain's stem cell niche [Last Updated On: July 26th, 2010] [Originally Added On: July 26th, 2010]
- 035 Prostate CSCs sensitive to gamma-tocotrienol? [Last Updated On: July 27th, 2010] [Originally Added On: July 27th, 2010]
- 036 Researchers Study CSCs as Therapeutic Targets for Mesothelioma [Last Updated On: July 28th, 2010] [Originally Added On: July 28th, 2010]
- 037 International Stem Cell Corporation and Sristi Biosciences Enter Distribution Agreement for Lifeline Cell Technology's Brand of Human Cell Culture... [Last Updated On: July 29th, 2010] [Originally Added On: July 29th, 2010]
- 038 Disagreement about melanoma CSCs [Last Updated On: July 29th, 2010] [Originally Added On: July 29th, 2010]
- 039 Cell of origin for human prostate cancer [Last Updated On: August 1st, 2010] [Originally Added On: August 1st, 2010]
- 040 International Stem Cell Corporation - Breakthrough Technology Alert [Last Updated On: August 6th, 2010] [Originally Added On: August 6th, 2010]
- 041 Oxygen, hypoxia and the stem cell niche [Last Updated On: August 7th, 2010] [Originally Added On: August 7th, 2010]
- 042 Partnership Pays Off [Last Updated On: August 17th, 2010] [Originally Added On: August 17th, 2010]
- 043 Video: Summary of Recent Developments in Stem Cell and Regenerative Medicine from Kenneth Aldrich, Chairman of International Stem Cell Corporation [Last Updated On: August 18th, 2010] [Originally Added On: August 18th, 2010]
- 044 International Stem Cell Corporation Formalizes Stem Cell Based Eye Care Programs into Cytovis™ [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 045 International Stem cell Corporation Chairman Discusses Recent Stem Cell Research Funding Decision [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 046 International Stem Cell Corporation Not Adversely Affected by Stem Cell Research Funding Ban [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 047 A Primer on the Use of Stem Cells in Ophthalmology by Irving J. Arons [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 048 Kenneth Aldrich, Chairman and Co-Founder of International Stem Cell Corporation will be making two public appearances this week on behalf of ISCO. [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 049 International Stem Cell Corporation Reports Significant Progress Towards Creation of the First Bank of Immune-Matched Human Parthenogenetic Stem Cells [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 050 International Stem Cell Corporation and Insight Bioventures India Structure Indian Affiliate to Develop Stem Cell-Based Eye Care Therapeutics... [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 051 ISCO to Present Data on Progress of Human Parthenogenetic Stem Cell Differentiation into Functional Liver Cells at the Annual Meeting... [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 052 Putative tumor-initiating progenitor cells predict poor lung cancer prognosis [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 053 Therapeutic implications of colon CSCs [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 054 Selective targeting of neuroblastoma tumour-initiating cells [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 055 Two Open Access reviews [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 056 Isolation and killing of candidate CML stem cells by antibody targeting [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 057 Some breast cancer tumors may not originate from stem cells? [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 058 On the low frequency of tumor-initiating cells [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 059 Must the last CML cell be killed? [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 060 Critical molecular pathways in CSCs of CML [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 061 Insights into the stem cells of CML [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 062 International Stem Cell Corporation Announces Launch Plans for New Skin Care Products [Last Updated On: October 16th, 2010] [Originally Added On: October 16th, 2010]
- 063 International Stem Cell Corporation Announces Completion of Its First Manufacturing Run of Lifeline Skin Care's Stem Cell-Based Skin Rejuvenation... [Last Updated On: October 26th, 2010] [Originally Added On: October 26th, 2010]
- 064 Notes from The Chairman Concerning ISCO Price Fluctuations [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- 065 Heightened Interest from the Medical Research Community and New Funding of International Stem Cell Corporation's (ISCO) Therapeutic Research [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- 066 International Stem Cell Corporation Announces the Commercial Launch of Its Breakthrough Stem Cell-Based Line of Skin Care Products [Last Updated On: December 10th, 2010] [Originally Added On: December 10th, 2010]
- 067 International Stem Cell Corporation Announces Commercial Sales to General Public of Its Breakthrough Stem Cell-Based Lines of Skin Care Products [Last Updated On: December 10th, 2010] [Originally Added On: December 10th, 2010]
- 068 International Stem Cell Corporation Announces $25 Million Common Stock Financing Agreement [Last Updated On: December 15th, 2010] [Originally Added On: December 15th, 2010]
- 069 International Stem Cell Corporation Announces Start of Marketing Collaboration with John Mauldin for Skin Care Products [Last Updated On: January 3rd, 2011] [Originally Added On: January 3rd, 2011]
- 070 International Stem Cell Corporation to Present Ethical and Technical Qualities of Human Parthenogenetic Stem Cells at the Center for Ethics in Science [Last Updated On: January 3rd, 2011] [Originally Added On: January 3rd, 2011]
- 071 Two new initiatives from the CSCC [Last Updated On: January 3rd, 2011] [Originally Added On: January 3rd, 2011]
- 072 A difference between normal and cancer SC biology in the nervous system [Last Updated On: January 7th, 2011] [Originally Added On: January 7th, 2011]
- 073 International Stem Cell Corporation Announces Company Update Conference Call [Last Updated On: January 15th, 2011] [Originally Added On: January 15th, 2011]
- 074 International Stem Cell Corporation Applauds Research Showing Parthenogenesis as a Potential Strategy for Treating Inherited Disease [Last Updated On: January 15th, 2011] [Originally Added On: January 15th, 2011]
- 075 International Stem Cell's Scientists in Collaboration with World Leading Stem Cell Experts Extend Understanding of Human Parthenogenetic Stem Cells... [Last Updated On: January 26th, 2011] [Originally Added On: January 26th, 2011]
- 076 International Stem Cell Corporation: A Multitude Of Potential Products From Its Parthenogenesis Technology by Jason Chew [Last Updated On: February 12th, 2011] [Originally Added On: February 12th, 2011]
- 077 International Stem Cell Corporation Demonstrates Progress in the Use of Immune Matched Human Parthenogenetic Stem Cells to Promote the Development... [Last Updated On: February 20th, 2011] [Originally Added On: February 20th, 2011]
- 078 International Stem Cell Corporation: Note From The CEO Andrey Semechkin [Last Updated On: February 20th, 2011] [Originally Added On: February 20th, 2011]
- 079 "A Little Egg On the Face" - LifeLine Skin Care Stem Cell Cream Article [Last Updated On: March 6th, 2011] [Originally Added On: March 6th, 2011]
- 080 International Stem Cell Corporation Updates on 2010 Initial Product Launch of its Lifeline Skin Care Products [Last Updated On: March 6th, 2011] [Originally Added On: March 6th, 2011]
